Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN)
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and continued efficacy of
perampanel in patients previously enrolled in double-blind, placebo-controlled studies for
Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN).